307 related articles for article (PubMed ID: 31669562)
21. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer.
Kataoka T; Kiyota N; Shimada T; Funakoshi Y; Chayahara N; Toyoda M; Fujiwara Y; Nibu K; Komori T; Sasaki R; Mukohara T; Minami H
Auris Nasus Larynx; 2016 Dec; 43(6):677-84. PubMed ID: 26992271
[TBL] [Abstract][Full Text] [Related]
23. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
[TBL] [Abstract][Full Text] [Related]
24. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
26. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
27. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
28. Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya GA
Oral Oncol; 2012 Sep; 48(9):893-7. PubMed ID: 22502814
[TBL] [Abstract][Full Text] [Related]
29. Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Vadhiraja BM
Radiother Oncol; 2012 Sep; 104(3):349-54. PubMed ID: 22884841
[TBL] [Abstract][Full Text] [Related]
30. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
32. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
[TBL] [Abstract][Full Text] [Related]
34. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.
Gujral MS; Patnaik PM; Kaul R; Parikh HK; Conradt C; Tamhankar CP; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S23-8. PubMed ID: 11561868
[TBL] [Abstract][Full Text] [Related]
36. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
37. Effect of Honey-Lemon Spray Versus Benzydamine Hydrochloride Spray on Radiation-Induced Acute Oral Mucositis in Head and Neck Cancer Patients: A Pilot, Randomized, Double-Blind, Active-Controlled Clinical Trial.
Ameri A; Poshtmahi S; Heydarirad G; Cramer H; Choopani R; Hajimehdipoor H; Azghandi S; Pasalar M
J Altern Complement Med; 2021 Mar; 27(3):255-262. PubMed ID: 33512251
[No Abstract] [Full Text] [Related]
38. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
39. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
Sangthawan D; Phungrassami T; Sinkitjarurnchai W
J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
[TBL] [Abstract][Full Text] [Related]
40. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]